The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
Open accessThe DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
Abstract
Opioid abuse has increased in the last decade, primarily as a result of increased access to prescription opioids. Physicians are also increasingly administering opioid analgesics for noncancer chronic pain. Thus, knowledge of the long-term consequences of opioid use/abuse has important implications for fully evaluating the clinical usefulness of opioid medications. Many studies have examined the effect of opioids on the endocrine system; however, a systematic review of the endocrine actions of opioids in both humans and animals has, to our knowledge, not been published since 1984. Thus, we reviewed the literature on the effect of opioids on the endocrine system. We included both acute and chronic effects of opioids, with the majority of the studies done on the acute effects although chronic effects are more physiologically relevant. In humans and laboratory animals, opioids generally increase GH and prolactin and decrease LH, testosterone, estradiol, and oxytocin. In humans, opioids increase TSH, whereas in rodents, TSH is decreased. In both rodents and humans, the reports of effects of opioids on arginine vasopressin and ACTH are conflicting. Opioids act preferentially at different receptor sites leading to stimulatory or inhibitory effects on hormone release. Increasing opioid abuse primarily leads to hypogonadism but may also affect the secretion of other pituitary hormones. The potential consequences of hypogonadism include decreased libido and erectile dysfunction in men, oligomenorrhea or amenorrhea in women, and bone loss or infertility in both sexes. Opioids may increase or decrease food intake, depending on the type of opioid and the duration of action. Additionally, opioids may act through the sympathetic nervous system to cause hyperglycemia and impaired insulin secretion. In this review, recent information regarding endocrine disorders among opioid abusers is presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, it is important to keep in mind that some medications (eg, high doses of heparins, phenobarbital, opioids, and etomidate) used in the ICU may adversely impact endocrine function or may alter the accuracy of laboratory testing (152, 153).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [153]
In the citing paper
“Opioids inhibit pulsatile GnRH secretion from the hypothalamus and the secretion of gonadotropins (mainly LH and to a lesser extent FSH) from the pituitary gland and of sex steroids from the gonads (61)(62)(63)(64).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [63]
In the citing paper
“In animals, depending on the dose, timing and duration, opioids have been shown to variably stimulate or inhibit the CRH/ACTH axis, whereas in humans they predominantly inhibit it [61].”
In the citing paper
“The physiological relationship between the opioid and OT systems has been firmly established (20).”
From Oxytocin under opioid antagonism leads to supralinear enhancement of social attention (2017) · cites this paper as [20]
Citations
Cites
Items 201–400 of 418
Mu Opioid Modulation of Oxytocin Secretion in Late Pregnant and Parturient Rats
Kutlu, S., Yilmaz, B., Canpolat, S., Sandal, S., Ozcan, M., Kumru, S., & Kelestimur, H. (2004) · Neuroendocrinology · doi:10.1159/000078101 · Cited by 42
Palm, S., Moenig, H., & Maier, C. (1997) · PubMed · Cited by 42
Borer, K. T., NICOSKI, D. R., & OWENS, V. (1986) · Endocrinology · doi:10.1210/endo-118-2-844 · Cited by 42
Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment
Müssig, K., Knaus‐Dittmann, D., Schmidt, H., Mörike, K., & Häring, H. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02779.x · Cited by 41 · cited 1×
“Several case reports have documented adrenal insufficiency after oral (185) or transdermal (186) opioid administration and during methadone administration (187).”
Giugliano, D., Ceriello, A., Pinto, P. D., Saccomanno, F., Gentile, S., & Cappiapuoti, F. (1982) · Diabetes · doi:10.2337/diab.31.4.367 · Cited by 41
Methionine-Enkephalin in Bone and Joint Tissues
Elhassan, A. M., Lindgren, J. U., Hultenby, K., Bergstrom, J., & Adem, A. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.88 · Cited by 40
(1990) · PubMed · Cited by 40
Naloxone evokes large-amplitude GnRH pulses in luteal-phase ewes
Horton, R. J. E., Cummins, J. T., & Clarke, I. J. (1987) · Reproduction · doi:10.1530/jrf.0.0810277 · Cited by 40 · cited 1×
“large LH pulse from the pituitary (214).”
The analgesic effect of morphine on postoperative pain in diabetic patients
Karcı, A., Tasdogen, A., Erkin, Y., Aktas, G., & Elar, Z. (2004) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2004.00387.x · Cited by 40 · cited 1×
“In diabetic patients, the analgesic effect of morphine was also lessened in diabetic and hyperglycemic conditions, and higher doses of morphine were needed for effective analgesia during postoperative pain (402).”
Vathy, I., Rimanóczy, Á., & Šlamberová, R. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00409-3 · Cited by 39
Clarke, G., & Patrick, G. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90073-3 · Cited by 39 · cited 4×
“In general, acute administration of opioids inhibits OT release (295, 301).”
InfluentialAnghel, A., Jamieson, C., Ren, X., Young, J., Porche, R., Ozigbo, E., Ghods, D. E., Lee, M. L., Liu, Y., Lutfy, K., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.043 · Cited by 38 · cited 1×
“(370) conducted a study that observed the”
Self-citationOPIATES ACT CENTRALLY ON GH AND PRL RELEASE
Panerai, A. E., Casanueva, F. F., Martini, A., Mantegazza, P., & Giulio, A. M. D. (1981) · Endocrinology · doi:10.1210/endo-108-6-2400 · Cited by 38
Orstead, K. M., Hess, D. L., & Spies, H. G. (1987) · Experimental Biology and Medicine · doi:10.3181/00379727-184-42485 · Cited by 38 · cited 1×
“Exogenous opioids and endogenous opioid peptides caused a significant decrease in LH pulse frequency (224), whereas naloxone promoted an increase in the LH surge compared with saline controls (225).”
Sustained Effects of Opioid Antagonism During the Normal Human Luteal Phase*
GINDOFF, P. R., JEWELEWICZ, R., HEMBREE, W., WARDLAW, S., & FERIN, M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-1000 · Cited by 37 · cited 1×
“However, naloxone did induce PRL release when administered for 7 d in the luteal phase of the menstrual cycle of healthy women, as reflected by an increase in LH and PRL pulse frequencies (132).”
Takahara, J., Kageyama, J., YUNOKI, S., Yakushiji, W., Yamauchi, J., Kageyama, N., & Ofuji, T. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90572-6 · Cited by 36
Endogenous opioids and hypogonadism in human obesity
Blank, D. M., Clark, R. V., Heymsfield, S. B., Rudman, D. R., & Blank, M. S. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90142-2 · Cited by 36 · cited 1×
“act to suppress GnRH secretion in obesity (388).”
Inenaga, K., Imura, H., Yanaihara, N., & Yamashita, H. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00423.x · Cited by 36
Effects of Endorphins on Prolactin and Growth Hormone Secretion in Rats
Kato, Y., Iwasaki, Y., Abe, H., Ohgo, S., & Imura, H. (1978) · Experimental Biology and Medicine · doi:10.3181/00379727-158-40219 · Cited by 36 · cited 1×
“This increase was attenuated by naloxone (71), suggesting that opioid receptors are involved in this response.”
THE PARTICIPATION OF HYPOTHALAMIC DOPAMINE IN MORPHINE‐INDUCED PROLACTIN RELEASE IN MAN
DELITALA, G., GROSSMAN, A., & BESSER, G. M. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00017.x · Cited by 35 · cited 2×
“Acute morphine administration increased serum PRL concentrations in men (118) as well as euthyroid and hypothyroid volunteers (119).”
The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
Knepel, W., & Meyer, D. K. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014820 · Cited by 35
Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone
Kobylecki, R. J., Carling, R. W., Lord, J. A. H., Smith, C. F. C., & Lane, A. C. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00344a005 · Cited by 35 · cited 1×
“The most commonly used antagonist is naloxone, which binds to -opioid receptors in a competitive manner (57).”
Daly, E. S. E. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00535-8 · Cited by 35 · cited 1×
“Another study found that an acute injection of morphine caused a rise in plasma and adenohypophysis ACTH and in hypothalamic CRH content at 5 and 25 min, followed by a fall in these hormones at 90 and 120 min (161).”
Vathy, I., van der Plas, J., Vincent, P. A., & Etgen, A. M. (1991) · Hormones and Behavior · doi:10.1016/0018-506x(91)90007-5 · Cited by 35
Oxytocin release is inhibited by opiates from the neural lobe, not those from the intermediate lobe
Bicknell, R. J., Ingram, C. D., & Leng, G. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90192-1 · Cited by 35 · cited 1×
“Opioids have been found to act directly at the neural lobe of the pituitary (335) to inhibit OT release in a variety of situations.”
Shook, J. E., Kachur, J. F., Brase, D. A., & Dewey, W. L. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25041-8 · Cited by 35
Bronstein, D. M., Day, N. C., Gutstein, H. B., Trujillo, K. A., & Akil, H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05820.x · Cited by 34
Endogenous codeine and morphine in anorexia and bulimia nervosa
Marrazzi, M. A., Luby, E. D., Kinzie, J. L., Munjal, I. D., & Spector, S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00133-1 · Cited by 34 · cited 1×
“Patients with anorexia and bulimia nervosa were found to have elevated levels of endogenous plasma levels of codeine and morphine; it is proposed that endogenous alkaloids are released during an initial dieting period that also reinforces the state of starvation (384).”
Dopaminergic and Serotonergic Involvement in Opiate-Induced Prolactin Release in Monkeys*
Wehrenberg, W. B., McNicol, D., Wardlaw, S. L., FRANTZ, A. G., & Ferin, M. (1981) · Endocrinology · doi:10.1210/endo-109-2-544 · Cited by 34 · cited 1×
“In contrast, in monkeys, PRL release is enhanced by serotoninergic pathways but is not affected by dopaminergic pathways (107).”
Enhanced prolactin levels in opium smokers
Moshtaghi‐Kashanian, G., Esmaeeli, F., & Dabiri, S. (2005) · Addiction Biology · doi:10.1080/13556210500351263 · Cited by 34 · cited 2×
“Eighty-seven percent of opium smokers in Iran had elevated PRL levels (124).”
(1986) · PubMed · Cited by 34
Gilbeau, P. M., Almirez, R. G., Holaday, J. W., & Smith, C. G. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-299 · Cited by 34
Effect of chronic morphine treatment on β-endorphine biosynthesis by the rat neurointermediate lobe
Gianoulakis, C., Drouin, J.-N., Seidah, N. G., Kalant, H., & Chrétein, M. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90569-0 · Cited by 33
ALLOLIO, B., DEUSS, U., KAULEN, D., LEONHARDT, U., KALLABIS, D., HAMEL, E., & WINKELMANN, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1427 · Cited by 33
Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
Cicero, T. J., Schmoeker, P. F., Meyer, E. R., Miller, B. T., Bell, R. D., Cytron, S., & Brown, C. C. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38976-7 · Cited by 33 · cited 1×
“However, in very young (10 to 30 d-old) male rats, naloxone failed to increase serum LH (228) and did not induce pubertal changes.”
Beta-Endorphin and Dynorphin Participate in the Stress-Induced Release of Prolactin in the Rat
Petraglia, F., Vale, W., & RIVIER, C. L. (2008) · Neuroendocrinology · doi:10.1159/000124756 · Cited by 32
Effect of Naloxone on the Hormone Response to crf in Normal man
Conaglen, J. V., Donald, R. A., Espiner, E. A., Livesey, J. H., & Nicholls, M. G. (1985) · Endocrine Research · doi:10.3109/07435808509035423 · Cited by 32 · cited 15×
“Subsequently, CRH binds to its receptor in the anterior pituitary that leads to the synthesis of POMC, a large precursor molecule that is cleaved into several smaller functional peptides, such as ACTH and -endorphin (67).”
InfluentialGabriel, S. M., Simpkins, J. W., Kalra, S. P., & Kalra, P. S. (2008) · Neuroendocrinology · doi:10.1159/000124049 · Cited by 31 · cited 1×
“(222) indicate that chronic morphine has no direct effect on LH, but that it enhances the sensitivity of the hypothalamus to negative feedback by testosterone in male rats.”
Siddiqui, A., Haq, S., & Shah, B. H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00012-9 · Cited by 31 · cited 1×
“(257), significantly reducing sexual behavior and repro-”
The effects of continuous morphine infusion on diet selection and body weight
Gosnell, B. A., & Krahn, D. D. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90292-n · Cited by 31
Clinical trial of naltrexone in premenstrual syndrome.
Chuong, C. J., Coulam, C. B., Bergstralh, E. J., O’Fallon, W. M., & Steinmetz, G. I. (1988) · PubMed · Cited by 30
Morphine suppresses the oxytocin response in breast-feeding women
Lindow, S. W., Hendricks, M. S., Nugent, F. A., Dunne, T. T., & van der Spuy, Z. M. (1999) · Gynecologic and Obstetric Investigation · doi:10.1159/000010130 · Cited by 30
Kappa Opiate Receptors Inhibit Release of Oxytocin from the Magnocellular System during Dehydration
Summy‐Long, J. Y., Rosella-Dampman, L. M., McLemore, G. L., & Koehler, E. (2008) · Neuroendocrinology · doi:10.1159/000125364 · Cited by 30
Sensitivity to β-endorphin as a cause of human obesity
Giugliano, D., Salvatore, T., Cozzolino, D., Ceriello, A., Torella, R., & D'Onofrio, F. (1987) · Metabolism · doi:10.1016/0026-0495(87)90135-1 · Cited by 30
Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose
Ceger, P. C., & Kuhn, C. M. (2000) · Psychopharmacology · doi:10.1007/s002130000413 · Cited by 29 · cited 1×
“In neonatal rat pups exposed to morphine, naloxone-induced opioid withdrawal suppressed GH levels in a dose-dependent manner (76).”
Shook, J. E., & Dewey, W. L. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25036-4 · Cited by 29 · cited 3×
“Shook JE, Kachur JF, Brase DA, Dewey WL 1986 Morphine dependence and diabetes.”
InfluentialNaloxone shortens ejaculation latency in male rats
Quarantotti, B. P., Paglietti, E., Bonanni, A., Petta, M., & Gessa, G. L. (1979) · Cellular and Molecular Life Sciences · doi:10.1007/bf01922747 · Cited by 28 · cited 1×
“In sexually inactive male rats, naloxone was able to induce copulatory behavior (246), and it reduced the number of intromissions before ejaculation and before the time of latency (247, 248).”
Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans
Brownell, J., del Pozo, E., & Donatsch, P. (1980) · Acta Endocrinologica · doi:10.1530/acta.0.0940304 · Cited by 28
Endorphinergic Mechanisms in Food, Salt and Water Intake: An Overview
Cooper, S. J., & Sanger, D. J. (1984) · Appetite · doi:10.1016/s0195-6663(84)80043-4 · Cited by 28
DETECTION OF VESICO-URETERIC REFLUX BY INDIRECT RADIONUCLIDE CYSTOGRAPHY
Gordon, I., & Barratt, T. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91131-8 · Cited by 28
Yang, J., Yang, Y., Xu, H., Chen, J.-M., Liu, W., & Lin, B.-C. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.09.003 · Cited by 28 · cited 1×
“AVP also enhanced periaqueductal gray-secreting enkephalin and -endorphin in the rat, suggesting that central AVP is an important bioactive substance for antinociceptive regulation (317).”
Khawaja, X. Z., Bailey, C. J., & Green, I. C. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90337-8 · Cited by 27
Morphine-induced TSH release in normal and hypothyroid subjects
Devilla, L., Pende, A., Morgano, A., Giusti, M., Musso, N. R., & Lotti, G. (2008) · Neuroendocrinology · doi:10.1159/000124091 · Cited by 27 · cited 2×
“Acute morphine administration increased serum PRL concentrations in men (118) as well as euthyroid and hypothyroid volunteers (119).”
Hendrie, C. A. (1988) · Physiology & Behavior · doi:10.1016/0031-9384(88)90257-0 · Cited by 27
Lightman, S. L., Langdon, N., & Forsling, M. L. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-6-1447 · Cited by 27 · cited 1×
“However, more recently, several studies using a variety of opioids including morphine (319), -endorphin (304, 319), leu-enkephalin analogs (320), and the met-enkephalin analogs, DAMME (321–323) and metkephamid acetate (324, 325), all indicate that opioids act directly to suppress AVP secretion.”
Lindow, S. W., Spuy, Z. M., Hendricks, M. S., Rosselli, A. P., Lombard, C., & Leng, G. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02337.x · Cited by 26 · cited 1×
“However, during the first stage of labor, morphine significantly inhibited plasma OT levels, whereas naloxone had no effect (345).”
Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice
Bailey, C. J., & Flatt, P. R. (1987) · Diabetologia · doi:10.1007/bf01788904 · Cited by 26 · cited 1×
“Enkephalin agonists for the - and -receptors increased glucose and insulin levels in both lean and obese mice (375).”
Carter, D., & Lightman, S. L. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90066-x · Cited by 26
Failure or opiates to reverse dopamine inhibition of prolactin secretion in vitro
Login, I. S., & MacLeod, R. M. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90227-9 · Cited by 26
Hypogonadism and Methadone: Hypothalamic Hypogonadism after Long-Term use of High-Dose Methadone
de la Rosa, R. E., & Hennessey, J. V. (1996) · Endocrine Practice · doi:10.4158/ep.2.1.4 · Cited by 26 · cited 3×
“Opioids are hypothesized to cause a decline in testosterone levels and sexual dysfunction via two mechanisms. de la Rosa and Hennessey (291) suggested that opioids lead to an alteration in normal gonadotropin pulse patterns or affect the response of the anterior pituitary to GnRH, both of which decreased testosterone…”
InfluentialDifferential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Bero, L. A., & Kuhn, C. M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00377-5 · Cited by 26 · cited 7×
“Bero LA, Kuhn CM 1987 Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.”
InfluentialMorphine induces delayed anorexia in rats
Leshem, M. (1988) · Psychopharmacology · doi:10.1007/bf00176855 · Cited by 25 · cited 1×
“suppressed intake again after 4 –24 h (359, 368).”
Kehoe, L., Parman, R., Janik, J. M., & Callahan, P. (2008) · Neuroendocrinology · doi:10.1159/000126448 · Cited by 25
Páez-Espinosa, V., Liu, Y., Ferrini, M. G., Anghel, A., Nie, Y., Tripathi, P. V., Porche, R., Jansen, E. J., Stuart, R. C., Nillni, E. A., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.063 · Cited by 25 · cited 6×
“Our laboratory has studied the effects of short-term (6 h) and chronic (7 d) morphine administration on levels of the prohormone convertases, PC1/3 and PC2 (137).”
InfluentialSelf-citationOpioid binding in a rat neurohypophysial fraction enriched in oxytocin and vasopressin nerve endings
Falke, N. E., & Martin, R. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90397-0 · Cited by 24 · cited 1×
“Endogenous opioids likely act directly at these neurosecretory nerve endings and not via pituicytes (312).”
Li, S., & Pelletier, G. (1993) · Neuroreport · doi:10.1097/00001756-199303000-00027 · Cited by 24
Opiate analgesics: the effect of agonist-antagonist character on prolactin secretion
Brown, B., Dettmar, P. W., Dobson, P. R. M., Lynn, A. G., Metcalf, G., & Morgan, B. A. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13348.x · Cited by 24
OPPOSITE EFFECTS OF MORPHINE ON FEEDING AND DRINKING IN RATS RELATIVE TO ADMINISTRATION TIME
Kunihara, M., Kanbayashi, M., & Ohshima, T. (1983) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.33.829 · Cited by 24
Acute Effects of Estradiol Infusion and Naloxone on Luteinizing Hormone Secretion in Pubertal Boys
Kletter, G. B., Padmanabhan, V., Beitins, I. Z., Marshall, J. C., Kelch, R. P., & Foster, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4458 · Cited by 24 · cited 1×
“Estradiol does not require the opioid receptor pathway for its negative feedback on the HPG axis during the early and middle stages of puberty (242).”
Morphine does not stimulate prolactin release during lactation
Callahan, P., Janik, J. M., Grandison, L., & Rabii, J. (1988) · Brain Research · doi:10.1016/0006-8993(88)91506-5 · Cited by 24 · cited 2×
“In contrast, -endorphin and a leu-enkephalin analog increased PRL during lactation in female rats (116).”
Lack of Effect of Opiates on Release of Vasopressin from Isolated Rat Neurohypophysis
Christensen, J. D., & Fjalland, B. (1982) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1982.tb00951.x · Cited by 23
Studies on the Role of Opiate Peptides in Two Forms of Genetic Obesity: ob/ob Mouse and fa/fa Rat
Recant, L., Voyles, N. R., Wade, A., Awoke, S., & Bhathena, S. (1983) · Hormone and Metabolic Research · doi:10.1055/s-2007-1018800 · Cited by 23 · cited 1×
“obese Zucker rats (fa/fa) compared with controls (371).”
Vugt, D. A. V., Baby, N., Stewart, M., & Reid, R. L. (2008) · Neuroendocrinology · doi:10.1159/000125209 · Cited by 23 · cited 1×
“In ovariectomized rats, the effect of a single injection of morphine on LH was dose-dependent, with an increase of LH after a high dose (10 mg/kg), but suppression of LH after a low dose (1 mg/kg) (204).”
Grevès, M. T.-L., Zhou, Q., Lagerholm, S., Huang, W., Grevès, P. L., & Nyberg, F. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01757-8 · Cited by 23
On the Origin of Leu-Enkephalin and Met-Enkephalin in the Rat Neurohypophysis
Zamir, N. (1985) · Endocrinology · doi:10.1210/endo-117-4-1687 · Cited by 23
Naloxone inhibits and morphine potentiates the adrenal steroidogenic response to ACTH
Heybach, J. P., & Vernikos-Danellis, J. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90337-x · Cited by 23 · cited 1×
“In hypophysectomized rats, a single dose of morphine potentiated and naloxone inhibited the adrenal steroidogenesis after exogenous ACTH administration (172).”
Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women
Hemmings, R., FOX, G. S., & Tolis, G. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46101-7 · Cited by 23 · cited 1×
“In postmenopausal women, a single dose of iv morphine increased PRL and decreased LH (121), demonstrating that morphine may affect a common receptor or neurotransmitter that controls both PRL and LH secretion from the anterior pituitary.”
Dutriez-Casteloot, I., Bernet, F., Dedieu, J. F., Croix, D., Laborie, C., Montel, V., Lésage, J., Beauvillain, J., & Dupouy, J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00086-5 · Cited by 23
Effects of naloxone infusions on pulsatile thyrotropin secretion
Samuels, M. H., Kramer, P. F., Wilson, D. A., & Sexton, G. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175985 · Cited by 22 · cited 1×
“Naloxone decreased TSH levels by suppressing the nocturnal surge in the TSH pulse amplitude, but did not affect daytime TSH levels or pulse frequency (156), supporting the finding that endogenous opioids stimulate TSH levels and affect the circadian rhythm of TSH (157).”
METHADONE-INDUCED HYPOADRENALISM
Pullan, P. T., Watson, F. E., Seow, S. S. W., & Rappeport, W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92011-1 · Cited by 22 · cited 1×
“Several case reports have documented adrenal insufficiency after oral (185) or transdermal (186) opioid administration and during methadone administration (187).”
Grossman, A. B., WEST, S., WILLIAMS, J., EVANS, J., REES, L. H., & BESSER, G. M. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb00722.x · Cited by 22 · cited 1×
“In hypothyroid patients, an infusion of naloxone did not change serum TSH levels (158), suggesting that endogenous opioids do not modulate TSH in this population.”
Byrnes, E. M. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.12.011 · Cited by 22 · cited 1×
“Morphine administered to juvenile female rats led to reduced sucklinginduced PRL secretion in adulthood, but other maternal behaviors were unaffected (117).”
Giugliano, D., Quatraro, A., Consoli, G., Ceriello, A., Torella, R., & D’Onofrio, F. (1987) · Metabolism · doi:10.1016/0026-0495(87)90190-9 · Cited by 22
Periovulatory beta-endorphin levels in premenstrual syndrome.
Cj, C., Bp, H., & Gibbons, W. E. (1994) · PubMed · Cited by 22
Aouizerate, B., Ho, A., Schluger, J. H., Perret, G., Borg, L., Le Moal, M., Piazza, P. V., & Kreek, M. J. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00006.x · Cited by 21 · cited 1×
“Overnight dexamethasone suppression testing resulted in lower cortisol levels in patients receiving methadone-maintenance therapy than in normal volunteers, indicating that methadone affects glucocorticoid feedback and that the interpretation of dexamethasone testing may be affected by treatment with methadone (188).”
Morphine-induced anorexia in lateral hypothalamic rats
Leshem, M. (1981) · Psychopharmacology · doi:10.1007/bf00433501 · Cited by 20 · cited 1×
“suppressed intake again after 4 –24 h (359, 368).”
Guaza, C., & Borrell, J. I. (1984) · Peptides · doi:10.1016/0196-9781(84)90113-x · Cited by 20 · cited 1×
“siveness of ACTH using dispersed adrenal cells (175).”
Carr, J. A., & Lovering, A. T. (2000) · Neuropeptides · doi:10.1054/npep.1999.0793 · Cited by 20
Alterations of plasma opioid activity in human diabetics
Awoke, S., Voyles, N. R., Bhathena, S. J., Tanenberg, R. J., & Recant, L. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90364-3 · Cited by 20 · cited 1×
“For example, patientswithdiabetes showed a 64% elevation of plasma -endorphin and a substantial increase in enkephalin-like immunoreactivity (400).”
Bivens, C. L. M., & Olster, D. H. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00042-8 · Cited by 19
Barbarino, A., Marinis, L. D., Mancini, A., D’AMICO, C., Passeri, M., Zuppi, P., Sambo, P., & TOFANI, A. (1987) · Metabolism · doi:10.1016/0026-0495(87)90001-1 · Cited by 19 · cited 1×
“In healthy women, naloxone infusion starting 1 h before GHRH administration reduced the GHRHinduced release of GH, whereas in healthy men, naloxone did not change this response (93).”
Mauras, N., Rogol, A. D., & Veldhuis, J. D. (1987) · Journal of Andrology · doi:10.1002/j.1939-4640.1987.tb03304.x · Cited by 18
Höllt, V., Haarmann, I., & Herz, A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb12532.x · Cited by 18
Villa, P., Valle, D., Mancini, A., Marinis, L. D., Pavone, V., Fulghesu, A. M., Mancuso, S., & Lanzone, A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00405-1 · Cited by 18 · cited 1×
“Opposite effects of naltrexone administration were found in women with polycystic ovary syndrome (PCOS), with an increased GH response after GHRH in lean PCOS women, whereas no effect was seen in obese PCOS women (98).”
Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro
Auernhammer, C. J., Stalla, G. K., Lange, M., Pfeiffer, A. F. H., & Müller, O. A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1322429 · Cited by 18 · cited 1×
“Moreover, loperamide, a -opioid agonist, did not change ACTH and cortisol levels in patients with Cushing’s syndrome, whereas it did suppress these levels in normal volunteers (197).”
The Effect of the Methionine Enkephalin Analogue DAMME on the Vasopressin Response to Tilt in Man
Lightman, S. L., & Forsling, M. L. (1980) · Clinical Science · doi:10.1042/cs0590501 · Cited by 18
Naloxone stimulates sexual behaviour in lactating rats
Forsberg, G., Eneroth, P. H. E., & Södersten, P. (1987) · Journal of Endocrinology · doi:10.1677/joe.0.1130423 · Cited by 18 · cited 1×
“havior (250), induced copulatory behavior in sexually in-”
Dual action of morphine on cold-stimulated thyrotropin secretion in male rats
Männistö, P. T., Rauhala, P. V., Tuominen, R. K., & Mattila, J. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90075-4 · Cited by 18
Acute Effects of Estradiol Infusion and Naloxone on Luteinizing Hormone Secretion in Pubertal Boys
Kletter, G. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4010 · Cited by 18
Evans, R. G., Olley, J. E., Rice, G. E., & Abrahams, J. M. (1989) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1989.tb01544.x · Cited by 17
Endocrine effects of methadone in rats; acute effects in adults
Bartolome, M. B., & Kuhn, C. M. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90639-8 · Cited by 17 · cited 1×
“Induction of stress resulted in a decrease of GH in male rats, whereas sc administration of morphine and methadone increased plasma GH levels (74, 75), suggesting that stress and opioids may influence GH release via separate mechanisms.”
Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment
D’Este, L., Casini, A., Pontieri, F. E., & RENDA, T. G. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.009 · Cited by 17 · cited 1×
“Acutely injected heroin increased immunoreactivity of neuropeptide Y in the thalamic paraventricular nucleus and nucleus of stria terminalis (366, 367), areas known to stimulate food intake and thus lead to an increased likelihood of obesity.”
Effect of opiates on growth hormone secretion in acromegaly
Bhansali, A., Velayutham, P., Sialy, R., & Sethi, B. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870230 · Cited by 17 · cited 2×
“In healthy subjects, the minimum morphine dose required for GH stimulation is approximately 15 mg (91).”
PITZEL, L., & K�nig, A. (1984) · Experimental Brain Research · doi:10.1007/bf00236277 · Cited by 17
Yang, S.-P., Lee, Y., & Voogt, J. L. (2000) · Neuroendocrinology · doi:10.1159/000054567 · Cited by 17 · cited 1×
“-Endorphinergic neurons in the arcuate nucleus participate in the acute response of PRL release after mating in female rats, suggesting that endogenous opioid peptides are involved in the neuronal transmission of genitosensory stimulation inducing PRL secretion (114).”
Morphine Antidiuresis in Conscious Rats: Contribution of Vasopressin and Blood Pressure *
Grell, S. N., Christensen, J. D., & Fjalland, B. (1985) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1985.tb01250.x · Cited by 17 · cited 1×
“rats (297), an effect blocked by naloxone, implying en-”
Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans
Plewe, G., Schneider, U., Krause, U., & Beyer, J. (1987) · Journal of Endocrinological Investigation · doi:10.1007/bf03347177 · Cited by 17 · cited 1×
“Obese patients exhibit lowered GH and PRL responses and higher -endorphin levels in response to raised opioid levels, an effect blocked by naloxone (386).”
Wolinsky, T. D., Abrahamsen, G. C., & Carr, K. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00994-8 · Cited by 17
Effects of systemic and epidural morphine on antidiuretic hormone levels in children
Bozkurt, P., Kaya, G., Yeker, Y., Altintas, F., Bakan, M., Hacibekiroglu, M., & Kavunoglu, G. (2003) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.2003.01096.x · Cited by 17 · cited 1×
“Intravenous or epidural morphine administered to children undergoing surgery raised AVP levels (326).”
Free and Bound Testosterone in Male Heroin Addicts
Lafisca, S., BOLELLI, G., Franceschetti, F., Danieli, A., Tagliaro, F., Marigo, M., & Flamigni, C. (1985) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-69928-3_83 · Cited by 17 · cited 1×
“testosterone levels (273), an effect that was not found in”
Effects of fentanyl on vasopressin secretion in human subjects.
Weiskopf, R. B., Reid, I. A., Fisher, D. M., Holmes, M. A., Rosen, J. I., & Keil, L. C. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39200-1 · Cited by 17 · cited 1×
“Infused fentanyl, an opioid stronger than morphine that is used as an anesthetic, increased AVP release in both surgical patients (327) and healthy volunteers (328).”
Mehmanesh, H., Almeida, O. F. X., Nikolarakis, K. E., & Herz, A. (1988) · Brain Research · doi:10.1016/0006-8993(88)90750-0 · Cited by 17
Graves, G. R., Kennedy, T. G., Weick, R. F., & Casper, R. F. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137898 · Cited by 17
EFFECTS OF HIGH‐DOSE AND LOW‐DOSE NALOXONE ON PLASMA ACTH IN PATIENTS WITH ACTH HYPERSECRETION
DEUSS, U., Allolio, B., KAULEN, D., Fischer, H., & Winkelmann, W. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb03240.x · Cited by 16 · cited 1×
“Additionally, naloxone stimulated ACTH levels in patients with Addison’s disease, but had no effect on ACTH levels in patients with Cushing’s disease (199).”
Vescovi, P. P., Pezzarossa, A., Ceresini, G., Rastelli, G., Valenti, G., & Gerra, G. (2008) · Hormone Research · doi:10.1159/000180040 · Cited by 16
Involvement of the hypothalamus in opiate-stimulated prolactin secretion
Dobson, P. R. M., & BROWN, B. L. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90065-1 · Cited by 16 · cited 1×
“Generally, opioids and their analogs stimulate PRL release from the anterior pituitary through an effect at the hypothalamus (99).”
Coiro, V., & Chiodera, P. (2008) · Neuroendocrinology · doi:10.1159/000125720 · Cited by 16 · cited 1×
“Naloxone has been shown to increase the angiotensin II-stimulated rise of OT secretion in male subjects (350).”
Tortella, F. C., & Holaday, J. W. (1986) · PubMed · Cited by 16
A synthetic opioid peptide increases plasma growth hormone and prolactin in Holstein calves1
Johnson, D. W., Barnes, M. A., Akers, R. M., & Pearson, R. E. (1993) · Journal of Animal Science · doi:10.2527/1993.7141004x · Cited by 15 · cited 1×
“However, across several species, a single systemic injection of morphine or an opioid agonist, such as DAMME or FK 33-824, has been shown to consistently increase serum PRL concentrations (80, 82, 102), and this effect was attenuated by naloxone in both heifers and rats (103–105).”
LOPERAMIDE, AN OPIATE ANALOGUE, INHIBITS PLASMA ACTH LEVELS IN PATIENTS WITH ADDISON'S DISEASE
Ambrosi, B., Bochicchio, D., & Faglia, G. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03276.x · Cited by 15 · cited 1×
“On the other hand, Addison’s disease patients treated with loperamide show sensitivity to opioids because the ACTH levels were decreased significantly with loperamide administration (201).”
Plasma levels of β-endorphin during the menstrual cycle
Ferrer, J., Mtnez-guisasola, J., Diaz, F., Alonscr, F., Guerrero, M., & Marín, B. (1997) · Gynecological Endocrinology · doi:10.3109/09513599709152516 · Cited by 15
Effects of acute and chronic morphine on food intake in rats: Modulation by oxytocin and vasopressin
Gulati, K., Ray, A., & Sharma, K. K. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90316-t · Cited by 15 · cited 1×
“The hyperphagic response to acute morphine was reduced by both AVP and OT (316).”
A new met-enkephalin analogue suppresses plasma vasopressin in man
Zerbe, R. L., Henry, D. P., & Robertson, G. L. (1982) · Peptides · doi:10.1016/0196-9781(82)90051-1 · Cited by 15
Roth, K. A., Lorenz, R. G., McKeel, D. W., Leykam, J. F., Barchas, J. D., & TYLER, A. N. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-804 · Cited by 15
Loperamide to Diagnose Cushing's Syndrome
Ambrosi, B., Bochicchio, D., Colombo, P., Fadin, C., & Faglia, G. (1993) · JAMA · doi:10.1001/jama.1993.03510190055022 · Cited by 15 · cited 1×
“In fact, lack of ACTH and cortisol suppression by loperamide was proposed to be an effective screening test for Cushing’s syndrome (198).”
Matera, C., Freda, P. U., Ferin, M., & Wardlaw, S. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852517 · Cited by 15
Jordan, D., Veisseire, M., Borson‐Chazot, F., & Mornex, R. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90324-1 · Cited by 14 · cited 1×
“phalin and met-enkephalin decreased TRH release (138).”
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids
Petraglia, F., Uberti, E. C. D., Trasforini, G., Facchinetti, F., Margutti, A., Volpe, A., Salvadori, S., Tomatis, R., & GENAZZANI, A. R. (1985) · Peptides · doi:10.1016/0196-9781(85)90317-1 · Cited by 14
Kletter, G. B., Foster, C. M., Brown, M. B., Padmanabhan, V., Beitins, I. Z., Marshall, J. C., & Kelch, R. P. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1241 · Cited by 14 · cited 1×
“In pubertal boys, naloxone administration had no effect on the negative feedback of testosterone on LH and GnRH levels (241).”
Bronstein, D. M., Gutstein, H. B., & Akil, H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03518.x · Cited by 14
Atypical responses to morphine in mice: A possible relationship to anorexia nervosa?
Buck, M., & Marrazzi, M. A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90457-7 · Cited by 14
Friedman, Z., Katznelson, R., Phillips, S. R., Zanchetta, C., Nistor, O.-I., Eisen, L. B., & Siddiqui, N. T. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00212.x · Cited by 14 · cited 1×
“Fully synthetic opioids are used as very powerful analgesics; fentanyl is about 75 times more potent than morphine (56).”
Opiate-Thyroid Hormone Interactions in the Regulation of Thyrotropin Secretion in the Rat
Berglund, A., Millard, W. J., Gabriel, S. M., & Simpkins, J. W. (2008) · Neuroendocrinology · doi:10.1159/000125602 · Cited by 14 · cited 1×
“In rats, the normal TSH decrease after opioid administration was no longer present after thyroidectomy, indicating that circulating thyroid hormones are required for morphine to have its suppressive effects on TSH levels (148).”
Evans, R. G., & Olley, J. E. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90291-1 · Cited by 14 · cited 1×
“In normally hydrated rats, morphine caused a dose-dependent reduction in plasma OT levels in virgin but not lactating rats (337), and similar OT levels were found in morphine-treated and untreated lactating rats (338).”
Endogenous Opiates Modulate Insulin Secretion in Flushing Noninsulin-Dependent Diabetics*
Mason, J. S., & Heber, D. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-4-693 · Cited by 14
Leshin, L. S., Rund, L. A., Thompson, F. N., Mahaffey, M. B., Chang, W. J., Byerley, D. J., & Kiser, T. E. (1990) · Journal of Animal Science · doi:10.2527/1990.6861656x · Cited by 13
Central opiate modulation of growth hormone and insulin-like growth factor-I
Hashiguchi, Y., Molina, P. E., Fan, J., Lang, C. H., & Abumrad, N. N. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00045-7 · Cited by 13 · cited 2×
“However, morphine-6-glucuronide did not produce any significant alterations in plasma GH and IGF-I levels, suggesting that differential affinities and/or selectivity of morphine and morphine-6-glucuronide to different opioid receptor/ subtypes might be responsible for their distinct effects on the GH/IGF-I system (70).”
Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia
Boulton, A. J., Wilson, N., Turnbull, K. W., & Yip, R. W. (1986) · Canadian Anaesthetists’ Society Journal · doi:10.1007/bf03010974 · Cited by 13
Stimulation of the Hypothalamic-Pituitary-Adrenal Axis with the Opioid Antagonist Nalmefene
Geer, E. B., Landman, R. E., Wardlaw, S. L., Conwell, I. M., & Freda, P. U. (2005) · Pituitary · doi:10.1007/s11102-005-5227-6 · Cited by 13
Olster, D. H. (1994) · Hormones and Behavior · doi:10.1006/hbeh.1994.1007 · Cited by 13
Little, P., & Kuhn, C. M. (1995) · Psychopharmacology · doi:10.1007/bf02246445 · Cited by 13 · cited 1×
“stimulate the release of stress hormones (160, 163).”
Physiological, pathophysiological and pharmacological aspects of exogenous and endogenous opiates.
Schick, R., & SCHUSDZIARRA, V. (1985) · PubMed · Cited by 13
Antidiuretic effect of acute morphine administration in the conscious rat
Wilson, N., & Ngsee, J. K. (1982) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y82-031 · Cited by 13 · cited 1×
“Morphine injection resulted in a mean decrease in arterial pressure and urine flow in both normal and Brattleboro rats that lack AVP (296), suggesting that the antidiuretic effect of morphine may occur independently of antidiuretic hormone release.”
Gabriel, S. M., Berglund, L. A., & Simpkins, J. W. (1987) · Endocrinology · doi:10.1210/endo-120-5-1799 · Cited by 13 · cited 1×
“also the estradiol surge-induced hypersecretion of LH, indicating that morphine amplifies both negative and positive feedback on gonadotropin secretion (223).”
Prenatal Exposure to Morphine Feminizes Male Sexual Behavior in the Adult Rat
Gagin, R., Cohen, E., & Shavit, Y. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00257-8 · Cited by 13 · cited 1×
“at 10–12 wk resulted in an increased lordosis quotient compared with placebo prenatal (260), which was interpreted as prenatal morphine giving long-lasting feminizing effects.”
Armstrong, J. D., & Spears, J. W. (1991) · Journal of Animal Science · doi:10.2527/1991.692774x · Cited by 13 · cited 1×
“a return to basal levels by 2–6 d after the infusion (79).”
Modulation of testicular functions by testicular opioid peptides.
Gerendai, I. (1991) · PubMed · Cited by 12
de Martin, R., & Voigt, K. H. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90196-5 · Cited by 12 · cited 1×
“(308), suggestingthatthisopioidpeptidemaybeasignificant”
Role of associative and nonassociative mechanisms in tolerance to morphine “anorexia”
Wolgin, D. L., & Benson, H. D. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90180-a · Cited by 12
Lindow, S. W., van der Spuy, Z. M., Hendricks, M. S., Nugent, F. A., & Dunne, T. T. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02425.x · Cited by 12 · cited 1×
“(344) showed that during late pregnancy, morphine and naloxone had no effect on the maternal OT levels.”
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects
Roti, E., Uberti, E. C. D., Salvadori, S., Bianconi, M., Emanuele, R., Rotola, C. A., Trasforini, G., ROBUSCHI, G., Tomatis, R., Griudi, A., et al. (1984) · Journal of Endocrinological Investigation · doi:10.1007/bf03348425 · Cited by 12
Effects of opiate antagonists on hormones and behavior of male and female rhesus monkeys
Abbott, D. H., Holman, S. D., Berman, M., Neff, D. A., & Goy, R. W. (1984) · Archives of Sexual Behavior · doi:10.1007/bf01542974 · Cited by 12 · cited 1×
“centration levels in either sex (212), suggesting that the”
Geis, R., Weber, E., de Martin, R., & Voigt, K. H. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90216-8 · Cited by 12
Rossmanith, W. G., Monn, M., & Benz, R. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00474.x · Cited by 12
Anatomical localization of enkephalin immunoreactive sites in rat forebrain.
Wamsley, J. K., Young, W. S., & Mj, K. (1980) · PubMed · Cited by 11
Bentley, A. M., & Wallis, M. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1090313 · Cited by 11 · cited 2×
“Direct incubation of morphine or morphine analogs on isolated perfused pituitaries had no effect on PRL release (100, 101).”
Naloxone suppresses buprenorphine stimulation of plasma prolactin
MENDELSON, J. H., MELLO, N. K., TEOH, S. K., LLOYD-JONES, J. G., & CLIFFORD, J. M. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198904000-00006 · Cited by 11 · cited 1×
“However, in a similar group of men, naloxone was able to reduce the increase of PRL after injection of buprenorphine (126).”
Willoughby, J. O., & Medvedev, A. V. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1480149 · Cited by 11 · cited 1×
“generator (84), an effect that has been shown to be medi-”
Differential responses in prolactin levels induced by naloxone in humans
Steardo, L., Monteleone, P., Tamminga, C. A., Canonico, P. L., Denman, D. W., Scapagnini, U., & Chase, T. N. (1985) · Psychoneuroendocrinology · doi:10.1016/0306-4530(85)90058-7 · Cited by 10 · cited 1×
“Postmenopausal estrogen-treated women injected with naloxone showed lower plasma PRL concentrations than the untreated reproductive-age control group (131).”
Opiate Receptor Blockade and Diurnal Pituitary and Adrenal Hormone Levels
Leslie, R. D. G., Prescott, R. W. G., Kendall-Taylor, P., Cook, D. M., Weightman, D., Ratcliffe, J. G., & Ingram, M. C. (1985) · Hormone and Metabolic Research · doi:10.1055/s-2007-1013458 · Cited by 10 · cited 1×
“Naloxone decreased TSH levels by suppressing the nocturnal surge in the TSH pulse amplitude, but did not affect daytime TSH levels or pulse frequency (156), supporting the finding that endogenous opioids stimulate TSH levels and affect the circadian rhythm of TSH (157).”
Beta-Endorphin Mediates Clonidine Stimulated Growth Hormone Release
Bruhn, T. O., Tresco, P. A., Mueller, G. P., & JACKSON, I. M. D. (2008) · Neuroendocrinology · doi:10.1159/000125263 · Cited by 10
Role of opioid peptides in pulsatile release of gonadotropins and prolactin in the rat
de Castro, J. C. B., Khorram, O., Petrović, S. L., & McCann, S. M. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90070-0 · Cited by 10 · cited 1×
“Furthermore, naloxone increased LH concentration and pulse frequency when administered alone (105), demonstrating a tonic opioid inhibition of LH secretion.”
Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects
Marinis, L. D., Mancini, A., Valle, D. D. L. N. M., Bianchi, A., Luca, A. D., Fulghesu, A. M., Villa, P., Mancuso, S., & Lanzone, A. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800519 · Cited by 10 · cited 3×
“In contrast, in obese women, naltrexone decreased basal concentration of both insulin and C-peptide, but did not affect the insulin secretory response to an oral glucose tolerance test (95).”
Briski, K. P., Quigley, K. L., & Meites, J. (1984) · Experimental Biology and Medicine · doi:10.3181/00379727-177-41956 · Cited by 10 · cited 1×
“Subcutaneous injection of naltrexone blocked the acute stress-induced decrease in plasma TSH and stopped the decline in TSH after chronic stressors, even slightly elevating TSH levels (143).”
Mikkelsen, J. D., Schmidt, P., Sheikh, S. P., & Larsen, P. J. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)62355-9 · Cited by 9
Pecins-Thompson, M., Widmann, A. A., & Bethea, C. L. (2008) · Neuroendocrinology · doi:10.1159/000127086 · Cited by 9
Jaworska-Feil, L., Budziszewska, B., & Lasoń, W. (1995) · Neuropeptides · doi:10.1016/0143-4179(95)90006-3 · Cited by 9
Plasma β-endorphin levels in obese and non-obese patients with polycystic ovary disease
Guisasola, J. M. M., Guerrero, M., Alonso, F., Dı́az, F., Cordero, J., & Ferrer, J. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.1.14.22 · Cited by 9
Dobado‐Berrios, P. M., Li, S., de Yebenes, E. G., & Pelletier, G. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00521.x · Cited by 9 · cited 2×
“(89), using in situ hybridization in rat pituitary, found a 22% decrease in GH mRNA levels after chronic (4-d) morphine administration.”
The effect of hyperthyroidism on opiate receptor binding and pain sensitivity
Edmondson, E. A., & Bonnet, K. A. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90160-s · Cited by 9 · cited 1×
“In mice, hyperthyroidism increased the binding of opioids to the opioid receptor and thus increased the serum TSH response to morphine and other opioids (145).”
Papalia, D., Lunetta, M., & Mauro, M. D. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03350058 · Cited by 9 · cited 1×
“(387) suggested that opioids do not directly regulate GH and PRL levels, but rather they stimulate cortisol and insulin response to insulin-induced hypoglycemia in obese females.”
Mitsuma, T., HIROOKA, Y., & NOGIMORI, T. (2008) · Hormone Research · doi:10.1159/000182700 · Cited by 9
Effects of morphine administration on the fetal production of oxytocin in labour.
Lindow, S. W., Hendricks, M. S., Thompson, J. W., et al. (1998) · PubMed · Cited by 9
Counteraction by Morphine of Stress-Induced Inhibition of Growth Hormone Release in the Rat
Briski, K. P., Quigley, K. L., & Meites, J. (1984) · Experimental Biology and Medicine · doi:10.3181/00379727-177-41923 · Cited by 9 · cited 1×
“Induction of stress resulted in a decrease of GH in male rats, whereas sc administration of morphine and methadone increased plasma GH levels (74, 75), suggesting that stress and opioids may influence GH release via separate mechanisms.”
Effects of morphine administration on the fetal production of oxytocin in labour
Lindow, S. W., HENDRICKS, M. S., THOMPSON, J. W., & van der Spuy, Z. M. (1998) · Clinical Science · doi:10.1042/cs19970159 · Cited by 9 · cited 1×
“Furthermore, fetal OT production was not affected by the administration of morphine to the mother (346).”
No effect of naloxone on plasma oxytocin in normal men
Honer, W. G., Thompson, C., Lightman, S. L., Williams, T. D. M., & Checkley, S. A. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90061-2 · Cited by 8 · cited 1×
“Another study showed that naloxone had no effect on baseline plasma OT levels in males (351).”
Suppression of Thyrotropin by Morphine in a Severely Stressed Patient
Ogrin, C., & Schussler, G. C. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.265 · Cited by 8 · cited 1×
“One case report found that morphine inhibited TSH secretion during stress (153).”
Tomasi, P. A., Fanciulli, G., Palermo, M., Pala, A., Demontis, M., & Delitala, G. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978827 · Cited by 8 · cited 1×
“Naloxone, in a constant infusion for 120 min, attenuated the stimulatory effect of GHRH on the secretion of GH, indicating the existence of an opioid-mediated stimulatory tone on GH secretion (92).”
The Ying-Yang hypothesis of opioid peptide immunomodulation.
Plotnikoff, N. P. (1985) · PubMed · Cited by 8
Effects of morphine on the pituitary-thyroid axis: morphological and analytical studies.
Soto, M. D. V., Iglesias, L., Calzada, B., Vega, J. A., Hernandez, L. C., & Pérez-Casas, A. (1991) · PubMed · Cited by 7
Effects of (D-Ala2, Met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.
Hashimoto, K., Suemaru, S., Hattori, T., Takao, T., INOUE, H. K., SUGAWARA, M., Kageyama, J., & Ota, Z. (1986) · Endocrinologia Japonica · doi:10.1507/endocrj1954.33.813 · Cited by 7 · cited 1×
“This was confirmed by a subsequent study examining the effects of naloxone in patients with primary aldosteronism suggesting that the zona fasciculata of the human adrenal gland may be a secondary site of action for opioids (203), similar to the findings in rodents (10, 177).”
Circulating levels of immunoreactive β-endorphin in polycystic ovary syndrome
Martinez-Guisasola, J., Ferrer, J., Guerrero, M., Díaz, F., Alonso, F., Bodega, A., Cordero, J., & Alonso-Briz, E. (1999) · Gynecological Endocrinology · doi:10.1080/09513599909167528 · Cited by 7
Interference of endogenous B endorphin with opiate binding in the anterior pituitary.
Rotten, D., Leblanc, P., Kordon, C., Weiner, R., & Enjalbert, A. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90009-0 · Cited by 7
Rossi, N. F., Kim, J., Summers, S. N., & Schrier, R. W. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00931-4 · Cited by 7
Henrohn, D., Grevès, P. L., & Nyberg, F. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00197-4 · Cited by 7 · cited 1×
“The involvement of opioid receptors in the effect of opioids on GH is supported by a study in human lymphoblastoid IM-9 cells that showed that morphine significantly altered GH receptor gene expression and GH binding in a naloxone-reversible manner (96).”
Janik, J. M., Klosterman, S., Parman, R., & Callahan, P. (2008) · Neuroendocrinology · doi:10.1159/000126721 · Cited by 7
Effect of intrathecal fentanyl on oxytocin secretion in pregnant women not in labour
SHIBLI, K. U., DHILLON, A. R., GOODE, J. A., GILBERT, C. L., THOMPSON, J. W., RUSSELL, I. F., & LINDOW, S. W. (2001) · Clinical Science · doi:10.1042/cs1010415 · Cited by 6 · cited 1×
“Other opioid analgesics, such as fentanyl or sufentanil, did not suppress OT levels before labor, but suppressed OT levels during the onset of labor (348, 349).”
Cantalamessa, F., Caro, G. D., & Perfumi, M. C. (1980) · Pharmacological Research Communications · doi:10.1016/s0031-6989(80)80094-4 · Cited by 6 · cited 1×
“tributed to the antidiuretic response in rats (305, 306).”
Bochicchio, D., Ambrosi, B., & Faglia, G. (2008) · Neuroendocrinology · doi:10.1159/000125070 · Cited by 6 · cited 1×
“Loperamide was seen to modify the effect of CRH on ACTH secretion in a nonadditive manner in Addison’s patients (202), such that ACTH release was inhibited.”
Mazzocchi, G., Robba, C., Rebuffat, P., Gottardo, G., & Nussdorfer, G. G. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90399-7 · Cited by 6
The effect of naloxone on ATCH and β-endorphin in patients with Cushing's disease
Baranowska, B., Dorobek, W., Misiorowski, W., Jeske, W., & Abdelfattah, M. H. (1985) · European Journal of Endocrinology · doi:10.1530/acta.0.1100170 · Cited by 6
μ-Opioid Agonists Stimulate Growth Hormone Secretion in Immature Rats
Eason, M. G., Francis, R. S., & Kuhn, C. M. (2008) · Neuroendocrinology · doi:10.1159/000127077 · Cited by 6
Wang, X., Tresham, J. J., Scoggins, B. A., & Coghlan, J. P. (1988) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1988.tb01029.x · Cited by 6
Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects
Villa, P., Valle, D. D. L. N. M., Marinis, L. D., Mancini, A., Bianchi, A., Fulghesu, A. M., Caruso, A., Mancuso, S., & Lanzone, A. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370631 · Cited by 6 · cited 1×
“Although chronic administration of naltrexone (50 mg/d for 4 wk) resulted in a 75% decrease in the GHRH-induced GH response in healthy premenopausal women (97), it resulted in a 3-fold increase of the GHRH-induced GH response in obese women (95), even though basal levels of GH, IGF-I, and IGF binding protein-3 were no…”
Cadet, P., Mantione, K. J., Bilfinger, T. V., & Stefano, G. B. (2002) · PubMed · Cited by 6
Effect of chronic opioid administration on glycosylated haemoglobin levels in heroin addicts.
Sood, A. K., Thakur, V., & Ahuja, M. M. S. (1989) · PubMed · Cited by 6
Growth hormone secretion in the obese male rat: modulation by the gonadal and thyroid axes.
Wj, M., Romano, T. M., Layden, M. P., Russell, W. E., & Rj, M. (1991) · PubMed · Cited by 6
Effects of morphine on urine flow in rats. Involvement of vasopressin.
Damase‐Michel, C., Montastruc, J., Valdiguié, P. M., & Montastruc, P. (1986) · PubMed · Cited by 6
Tj, C. (1984) · PubMed · Cited by 6
Opiate Receptor Subtypes in the Regulation of Thyrotropin and Prolactin Secretion in the Rat
Rauhala, P. V., Tuominen, R. K., & Männistö, P. T. (2008) · Hormone Research · doi:10.1159/000181007 · Cited by 5 · cited 2×
“The -agonist MR 2034 acted similarly as morphine, inhibiting the cold-stimulated TSH response when infused into the third ventricle and increasing the TSH response when infused in the posterior hypothalamus (147).”
Research works printed but not linked: 2
- 2009, International Narcotics Control Board 2007, March, press release no. 4: Abuse of prescription drugs to surpass illicit drug abuse, Drug Watch International, 12, 14
- Mansour, 1987, Autoradiographic differentiation of μ, δ, and κ opioid receptors in the rat forebrain and midbrain., J Neurosci, 7, 2445
Cited by
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
Clinical Management of Congenital Hypogonadotropic Hypogonadism
Young, J., Xu, C., Papadakis, G. E., Acierno, J. S., Maione, L., Hietamäki, J., Raivio, T., & Pitteloud, N. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00116 · Cited by 396
Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction
Andersson, K.-E. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004515 · Cited by 392
“…injection of opioids can lead to decreased libido and ED (Parr, 1976; Crowley and Simpson, 1978; Mirin et al., 1980; Abs et al., 2000; Hallinan et al., 2008), possibly because of hypogonadotropic hypogonadism (Mirin et al., 1980; Abs et al., 2000; Hallinan et al., 2008; Vuong et al., 2010).”
BackgroundJanssen, P., Vanden Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 348
“whether normal weight, low weight (anorexia patients) or obese volunteers ⁄ patients are selected.(132) We recently”
BackgroundBasaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Metadata
- Authors
- Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C.
- Affiliations
- Charles R. Drew University of Medicine and Science (US)
- Department of Medicine (S.H.M.V.U.), University of Western Ontario, London, Ontario, Canada N6A 4V2;
- Department of Psychology (L.E.O.), University of Texas at El Paso, El Paso, Texas 79968;
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2009-11-10
- Volume
- 31
- Issue
- 1
- Pages
- 98-132
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2852206
- OpenAlex
- W2121855288
- Semantic Scholar
- b1cd06bbab24029ae38ff691e325cd99457b8455
- Cited by
- 564
- References
- 418
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 25 · 2023: 34 · 2022: 36 · 2021: 37 · 2020: 35 · 2019: 41 · 2018: 52 · 2017: 32 · 2016: 37 · 2015: 42 · 2014: 34 · 2013: 29 · 2012: 32
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u54rr014616-10)
- National Institute on Drug Abuse (R01DA014659, R01 DA14659, R01 DA16682, R01DA016682, R01DA021274, R24DA017298, R25DA033613)
- National Center for Research Resources (U54-RR14616, G12RR003026, U54-RR0 14616, G21 RR03026)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD41748, U54HD041748)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- opioids, opioid analgesics, endocrine effects, growth hormone, prolactin, luteinizing hormone, testosterone, estradiol, oxytocin, thyroid-stimulating hormone, vasopressin, ACTH, opioid receptors, hypogonadism, dietary intake, hyperglycemia, insulin secretion, chronic pain, opioid abuse
- MeSH terms
- Analgesics, Opioid, Animals, Endocrine System Diseases, Endocrine System, Female, Humans, Hypogonadism, Male, Opioid-Related Disorders, Opiate Alkaloids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.